Susan Bobulsky sold $544K of Adaptive Biotechnologies (ADPT)

Executed Mar 11, disclosed Mar 13, 2 days later.

Value, as filed

$544K

41,338 sh × $13.17

Executed

Mar 11

the trade date, as filed

Disclosed

Mar 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Susan Bobulsky Chief Commercial Officer, MRD profile →

Susan Bobulsky (Chief Commercial Officer, MRD) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $544K of ADPT (41,338 sh × $13.17, as filed), executed Mar 11.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 80 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Susan Bobulsky in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $193K
6,444 sh × $30.00
Exec Oct 6
Filed Oct 8 · 6:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation $115K
5,000 sh × $23.00
Exec Jul 16
Filed Jul 20 · 7:19 PM ET ADPTSALE Adaptive Biotechnologies Corporation $102K
5,000 sh × $20.50
Exec Jun 25
Filed Jun 29 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $198K
11,000 sh × $18.00
Exec Jun 4
Filed Jun 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $182K
26,023 sh × $6.98
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET